BC
Boxer Capital Portfolio holdings
AUM
$2.04B
1-Year Return
108.35%
This Quarter Return
+30.1%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$935M
AUM Growth
+$388M
(+71%)
Cap. Flow
+$264M
Cap. Flow
% of AUM
28.28%
Top 10 Holdings %
Top 10 Hldgs %
69.63%
Holding
34
New
8
Increased
14
Reduced
2
Closed
2
Top Buys
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$46.1M |
| 2 |
Rocket Pharmaceuticals
RCKT
|
+$32.2M |
| 3 |
Wave Life Sciences
WVE
|
+$32M |
| 4 |
DBVT
DBV Technologies
DBVT
|
+$23.5M |
| 5 |
PTC Therapeutics
PTCT
|
+$22.9M |
Top Sells
| 1 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
+$10.3M |
| 2 |
ARDM
Aradigm Corp Common Stock
ARDM
|
+$6.7M |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$6.08M |
| 4 |
RGLS
Regulus Therapeutics
RGLS
|
+$360K |
Sector Composition
| 1 | Healthcare | 94.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DERM
26
DELISTED
Dermira, Inc.
DERM
| $4M | 0.43% |
+500,000
| New | +$4M |
|
|
BLPH
27
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $3.86M | 0.41% |
123,810
| – | – |
|
|
BLCM
28
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $2.3M | 0.25% |
+35,000
| New | +$2.3M |
|
29
Eledon Pharmaceuticals
ELDN
$145M
| $1.64M | 0.17% |
+18,021
| New | +$1.64M |
|
30
Syndax Pharmaceuticals
SNDX
$1.34B
| $1.42M | 0.15% |
100,000
| – | – |
|
|
RGLS
31
DELISTED
Regulus Therapeutics
RGLS
| $1.22M | 0.13% |
14,148
-4,167
| -23% | -$360K |
|
|
ONTXW
32
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
| $72K | 0.01% |
241,644
| – | – |
|
|
CNCE
33
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| – | – |
-400,000
| Closed | -$10.3M |
|
|
ARDM
34
DELISTED
Aradigm Corp Common Stock
ARDM
| – | – |
-1,000,000
| Closed | -$6.7M |
|